The Sabin Vaccine Institute has begun a Phase II trial in the US to evaluate its Marburg vaccine, with the first doses being ...

In 2024, the CDC worked with the WHO to respond to a Marburg virus outbreak in Rwanda that lasted for several months. On average, about half of people infected with Marburg virus do not survive ...

Marburg virus, if left untreated ... In a statement this month, the U.S. Centers for Disease Control and Prevention (CDC) said that the agency and its partners in Africa continue to work together ...

Complex Pandemic Accord negotiations have been under way since 2021, with 13 formal meetings and numerous informal sessions.

Reports of the fast spreading Marburg virus has raised concerns about the ... There have been 66 illnesses and 15 deaths in Rwanda, according to the CDC, but many more may be infected.

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent 09.04.2025 / 15:07 CET/CEST The issuer is solely responsible ...

Dr. Ngashi Ngongo, the Principal Advisor to the Director General of Africa CDC on Programs, represented H.E. Dr. Jean Kaseya at the official handover ceremony in Luanda.